HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CFSAN

This article was originally published in The Rose Sheet

Executive Summary

FDA to hold a public meeting to "solicit input on program priorities and establish work product expectations" as part of a "comprehensive review" of the Center for Food Safety & Applied Nutrition operations, a June 3 Federal Register notice states. In CFSAN's regulatory program, priorities are assigned as follows: regulations that enhance consumer safety; regs mandated by statute; health-related product labeling requirements; and regs to improve operating efficiency. The agency asks commenters to list their top research priorities for CFSAN and consider whether there are consumer safety issues not being addressed by the center. The meeting is scheduled for June 24 and 25 at the Cohen Bldg., 330 Independence Avenue, SW, Washington, D.C...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS005481

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel